New pill shrinks pancreatic tumours in most trial patients
The Guardian reported that a drug called daraxonrasib has shown promising results in a trial involving patients with advanced pancreatic cancer that had…
The Guardian reported that a drug called daraxonrasib has shown promising results in a trial involving patients with advanced pancreatic cancer that had spread beyond the pancreas. In the study, tumours stopped growing in almost all of the 61 participants, and in one out of twelve patients the cancer became undetectable. The trial enrolled people who had recently been diagnosed with the disease at an advanced stage. Researchers said the pill was able to shrink and, in some cases, potentially eliminate the tumours. The findings have been described as the biggest breakthrough in pancreatic‑cancer treatment in decades.
The trial’s outcomes suggest that daraxonrasib could become a new therapeutic option for patients with limited treatment choices, offering hope for improved survival and quality of life.
Why it matters
The results point to a possible new treatment for a cancer that is often diagnosed late and has few effective therapies.
Key details
- Location
- United Kingdom · Europe
- Reported by
- The Guardian
- First reported
- Section
- Health
Sources
This is an independent summary. Read the full, original reporting from the publisher:
Read the full story at The GuardianSpotted an error? Request a correction · How this summary was produced
Related Stories
NHS England likely to miss cancer treatment target, risking 10,000 delayed patients
The Guardian reported that NHS England is on track to fall short of its interim cancer‑treatment goal, potentially leaving almost 10,000 patients…
Florid language and long silences: five things we learned from week three of Russell Brand’s rape trial
The former comedian and his wife gave evidence in the case in which he denies all charges against him Russell Brand’s trial at Southwark crown court…
Russell Brand told police he led a ‘very promiscuous’ life, trial hears
The Guardian reported that comedian Russell Brand, 51, told police he had led a “very promiscuous” life and that consensual sexual encounters were…
‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows
It is the first individualised cancer vaccine to show positive results in a phase III clinical trial.
NSW health warns after three vape users hospitalised with unregistered sedative
Three people in New South Wales were hospitalised after losing consciousness while using certain vape products, according to The Guardian.
Baby born with heart abnormalities ‘didn’t have a chance’ after non-medical free birth, NSW inquest hears
Baby DH, Baby D, Baby R, and Baby B died in the state’s northern rivers region between 2022 and 2024.
Patient discovers therapist notes shared with over 100,000 NHS staff
The Guardian reported that the Information Commissioner’s Office has opened an investigation after a patient learned that her confidential therapist…
Judge finds Thomas Markle mentally fit to stand trial on child abuse charges
Markle, who has denied possessing images of child sex abuse was deemed competent after an evaluation by a court-appointed psychiatrist.







